An educational webinar series featuring leading clinical experts in the field of breast radiology and innovative cancer therapy hosted by iCAD and Xoft
Intelligence artificielle pour le cancer du sein : révolution actuelle et future pour un meilleur dépistageSamedi 8 octobreLe Pr Bruno Boyer, CIMI, Paris explique le rôle et l’impact clinique de l’utilisation des solutions d’intelligence artificielle d’iCAD en pratique quotidienne à travers des exemples de cas cliniques et le Pr Corinne Balleyguier de l’Institut Gustave Roussy présente les résultats d’études cliniques montrant les performances des solutions d’IA pour la détection du cancer du sein, mais aussi pour la prédiction du risque à court terme avec ProFound AI Risk afin d’identifier les patientes à risque élevé pour adapter leur suivi.ProFound Insights, ProFound Impact: ProFound AI Risk in the Real-WorldMonday, July 18, 2022Back by popular demand! Leading experts, Dr. Mark Trail and Dr. Axel Gräwingholt, returned to our virtual stage for an encore “ProFound Insights, ProFound Impact” event and clinical case study review.Join us as we take a deeper dive into a range of real-world cases and discover how the ProFound AI Breast Health Suite can help radiologists find cancers earlier and improve outcomes for patients.ProFound Insights, ProFound Impact: Risk Assessment ReimaginedTuesday, June 21, 2022Discover the power of ProFound AI® Risk, the latest addition to iCAD’s breast AI suite and the world’s first clinical decision support tool that provides an accurate, short-term breast cancer risk estimation that is truly personalized for each woman, based only on her mammogram.Watch as we sit down with leading experts who will discuss the significant impact of ProFound AI Risk, including distinguished researcher from the Karolinska Institutet and clinicians who are using it in daily practice.ProFound Insights, ProFound Impact: Why ProFound AI Prevailed as the Premier AI Solution in a Competitive Trial at Wake RadiologyTuesday, May 10, 2022With 14 imaging locations in the Raleigh-Durham metropolitan area, Wake Radiology offers a wide array of imaging exams in the outpatient setting, including both screening and diagnostic mammography. But when the facility upgraded to 3D mammography, the organization soon realized that the substantial increase in the volume of images compared to 2D mammography resulted in workload challenges for its radiologists.ProFound Insights, ProFound Impact: Why Kettering Health Traded out Previous AI Software for ProFound AI® Enterprise-WideWednesday, April 27, 2022Experience a compelling conversation featuring leading experts in breast imaging and hospital administration from Kettering Health, a leading enterprise breast care provider with 14 breast centers across southwest Ohio, and discover how iCAD’s world-class AI breast health solutions offer a trifecta of unrivaled, clinically proven benefits to patients, clinicians and facilities.Solutions d’intelligence artificielle pour la détection du cancer du sein et l’évaluation du risqueMardi 19 avril 2022Près de 5 millions de mammographies sont effectuées en France chaque année. Les solutions d’IA pour la détection du cancer du sein sont devenues une aide précieuse au quotidien pour les radiologues.Panorama sur la mise en place l’IA pour la détection du cancer du sein : impacts cliniques, dépistage personnalisé, aspects économiques et juridiques à travers les retours d’expérience d’utilisateurs des solutions ProFound AI® d’iCAD.Symposium, JFR21
L’intelligence artificielle pour la détection précoce du cancer du seinDimanche 10 octobreLe Dr Arfi Rouche de l'Institut Gustave Roussy et le Dr Toubiana du C.S.E à Paris, reviennent sur les différentes études cliniques montrant les performances des solutions ProFound AI® pour une meilleure détection du cancer du sein. Ils expliquent comment ces solutions qui font aujourd’hui parties intégrantes du workflow clinique des centres d’imagerie privés comme publics, les aident au quotidien au travers d'exemples de cas cliniques.Pandemic Recovery: How New Technology Can Support Clinicians and Patients in the Aftermath of COVID-19Tuesday, September 14, 2021As we shift from the peak of the pandemic to recovery mode, clinicians are in need of new solutions to navigate today’s challenges. During this virtual event, leading experts from the breast care community shared insights about new innovations in imaging and risk-assessment that may help the clinical community address emerging pandemic challenges, and best practices for how facilities can recuperate from the impact of COVID-19.What is Real AI: Adopting Artificial IntelligenceTuesday, September 15, 2020This free virtual roundtable will feature leading experts in artificial intelligence (AI) and cancer detection, who will share best practices on how to leverage AI in a clinical setting – in the era of COVID-19 and beyond. Join us to learn how AI can improve efficiency and enhance patient care in your practice.Satisfying the Triple Aim: IORT and its Benefits for Clinicians, Patients and PayersTuesday, July 21, 2020Intraoperative radiation therapy (IORT) offers a unique trifecta of benefits for clinicians, patients, and payers. In partnership with the Society for Radiation Oncology Administrators (SROA), leading breast cancer specialists will share clinical experiences and expert opinions regarding this targeted, single-fraction radiation treatment option, which optimizes workflow and allows women who are candidates to get the treatment they need, while minimizing potential COVID-19 exposure to patients and clinicians.Webinaire, L’Intelligence Artificielle pour une meilleure détection du cancer du seinTuesday, July 7, 2020Présenté par le Dr Toubiana et Benillouche, CSE Paris. Comment les solutions ProFound AI™ pour la mammographie et la tomosynthèse assistent le radiologue au quotidien. a solution ProFound AI™ est utilisée au centre d’imagerie CSE à Paris depuis Septembre 2018. Les Drs Toubiana et Benillouche montrent, au travers de nombreux cas cliniques, comment l’utilisation de ce nouvel outil a changé leur routine clinique pour l’analyse des mammographies 2D et tomosynthèses.In Partnership with the TME Breast Care Network “It’s TiME” Series: Behind the Mask – Operating with Precision, Efficiency, and EmpathyTuesday, June 23, 2020While Coronavirus force functioned healthcare systems into care delivery redesign, physicians were challenged to rethink best-in-class surgical and radiation practice. eoperation, re-excision, and unnecessary treatment time now threaten more than margin efficiency and patient outcomes – inefficiency is an opportunity for unintended exposure.In Partnership with the TME Breast Care Network “It’s TiME” Series: Catching up with Catching Cancer EarlyTuesday, June 9, 2020Adopting the right technology and innovation can yield improved patient access and outcomes as the industry navigates the back log of elective procedures from screening to surgery. Specifically in this session, TME leaders will explore the importance of maintaining a focus on population health and how to support patients through at-home preventative care.GE Healthcare: Making AI Meaningful - How AI is Being Used to Transform Radiology PracticesThursday, May 28, 2020The use of Artificial Intelligence (AI) in radiological applications is no longer an idea - it is becoming a necessity to help deliver the highest possible patient care. Just as PACS and RIS systems were the crucial infrastructure implementation of the last 20 years in the transition of radiology from film to digital, AI is one of the new crucial enabling technologies of this decade’s radiology practices.How Radiologists can Easily and Effortlessly Integrate Artificial Intelligence in Breast Screening During and After the COVID-19 CrisisMonday, May 18, 2020Michael Gruber, MD, will explain how he uses ProFound AI in his breast screening program, how AI was easy to implement and immediately assisted him in addressing the challenges of tomosynthesis.Live Roundtable Replay and Q&A with Dr. Randy Hicks: Breast Cancer Screening and Treatment in the Era of COVID-19Thursday, May 7, 2020In partnership with the Targeted Medical Education (TME) Breast Care Network, our Virtual Roundtable Event featured leading breast cancer specialists nationwide who discussed their perspectives and experience regarding how COVID-19 is changing the future of breast cancer care.Assisting Radiologists: How can AI Improve the Efficiency of Breast Healthcare After COVID-19?Monday, May 4, 2020How can AI improve the efficiency of breast healthcare after COVID-19 and help radiologists with their increased workload? After the COVID-19 crisis, radiologists will have to deal with an influx of patients due to rescheduled examinations.* Webinar intended for an EU audience.Work Smarter, Not Harder: Boost your Bottom Line with AIThursday, April 30, 2020Are you working harder or working smarter? Artificial intelligence (AI) can not only improve your workflow, it can also have a positive impact on your practice’s bottom line. Join us for a brief discussion with Dr. Gabriele Pedicelli, radiologist at Wooster Community Hospital, to learn how a leading-edge AI tool can empower your practice to increase the number of cases seen per day and increase revenues without increasing expenses.Trustworthy Tools: Leveraging the Power of AI to Improve AccuracyThursday, April 23, 2020False positives and patient callbacks can cause unnecessary stress for patients, but a cutting-edge artificial intelligence (AI) solution offers a tool radiologists can trust to improve reading accuracy. Join us for a brief discussion with Lisa Sheppard, MD, radiologist at PINK Breast Center, to learn how AI helped improve her practice’s biopsy accuracy, while also reducing the number of false positives and callbacks.Assisting Radiologists: How can AI Improve the Efficiency of Breast Healthcare After COVID-19?Tuesday, April 21, 2020How can AI improve the efficiency of breast healthcare after COVID-19 and help radiologists with their increased workload? After the COVID-19 crisis, radiologists will have to deal with an influx of patients due to rescheduled examinations.* Webinar intended for an EU audience.Breast Care Virtual Roundtable: How is breast cancer screening and treatment evolving in the era of COVID-19?Tuesday, April 21, 2020In partnership with the Targeted Medical Education (TME) Breast Care Network, our Virtual Roundtable Event featured leading breast cancer specialists nationwide who discussed their perspectives and experience regarding how COVID-19 is changing the future of breast cancer care.The Power of Artificial Intelligence for Digital Breast TomosynthesisThursday, April 16, 2020Join us for an informative discussion about how the concurrent use of AI improves sensitivity, specificity and reading time when reading Digital Breast Tomosynthesis (DBT) cases. Dr. Mark Traill will discuss real-world experiences and clinical perspectives in breast health solutions powered by artificial intelligence.
IORT: Can a New Multidisciplinary Approach Make a Difference in Treating Brain Tumors?Tuesday, May 25, 2021Join us for a free virtual roundtable discussion featuring leading experts in Neuro-oncology who will share how intraoperative radiation therapy (IORT) is emerging as a multidisciplinary approach for the treatment of brain tumors.IORT Applied During and Post Pandemic TimesTuesday, June 30, 2020Join us for an informative webinar featuring leading breast cancer experts from Anadolu Medical Center in Istanbul, Turkey who will discuss how breast intraoperative radiation therapy (IORT) is optimizing workflow and minimizing COVID-19 exposure to patients and clinicians, while preserving high-quality care. Prof. Hale Çağlar, Metin Çakmakçı, and Nadir Küçük, MSc. will share their views on the impact of the pandemic on their practice, hypofractionation, IORT as boost and emerging IORT applications.Electronic Brachytherapy (eBx) for Gynecological TumorsThursday, Jun 25, 2020Gynecological cancers require, in many cases, the use of brachytherapy as part of the standard course of treatment. The Xoft System allows clinicians to perform gynecological brachytherapy with multiple dwell positions to deliver the prescribed dose without the inconvenience of radioactive sources. Learn more about gynecological cancer treatment with the Xoft System from Dr. Arantxa Campos and Dr. Sonia Flamarique from Miguel Servet University Hospital from Zaragoza, Spain.The Impact of COVID-19 on Breast Cancer Surgery and Targeted Radiation TherapyThursday, June 4, 2020How are clinicians changing their approach to cancer treatment during the COVID-19 pandemic? Join us for a free virtual roundtable featuring leading breast cancer experts who will share best practices and discuss how targeted radiation therapy is emerging as a way to optimize workflow and minimize COVID-19 exposure to patients and clinicians, while preserving high-quality care.Xoft Breast Intraoperative Radiation Therapy (IORT) for Early Stage Breast Cancer TreatmentThursday, May 21, 2020Explore an innovative approach to breast cancer treatment. Join us for a free webinar to learn how IORT has optimized Dr. Grumley’s workflow and how targeted radiation therapy is emerging as a way to minimize COVID-19 exposure to patients and clinicians, while preserving high quality care.Xoft Intraoperative Radiation Therapy (IORT) for Brain Cancer: Local Tumor Control in Patients with Recurrent GlioblastomaTuesday, May 19, 2020Worldwide, almost 297,000 cases of brain and nervous system tumors are diagnosed per year. Glioblastoma is the most common and aggressive type of malignant primary brain tumor, with a median survival of 10-12 months. Learn more about the promising preliminary results of this procedure after GBM relapse. Join Professor Krivoshapkin & Dr. Gaytan for an informative product showcase discussing Neuro IORT and the benefits it offers to physicians, facilities and patients.Xoft Intraoperative Radiation Therapy (IORT) for Brain Cancer: Local Tumor Control in Patients with Recurrent GlioblastomaThursday, May 14, 2020Worldwide, almost 297,000 cases of brain and nervous system tumors are diagnosed per year. Glioblastoma is the most common and aggressive type of malignant primary brain tumor, with a median survival of 10-12 months. Learn more about the promising preliminary results of this procedure after GBM relapse. Join Professor Krivoshapkin & Dr. Gaytan for an informative product showcase discussing Neuro IORT and the benefits it offers to physicians, facilities and patients
© iCAD Inc. All rights reserved. iCAD, the iCAD logo, PowerLook, ProFound AI, ProFound, Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are registered trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.